Options
2026
Journal Article
Title
Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL)
Abstract
Background: Symptomatic dermographism (SD) is the most common subtype of chronic inducible urticaria. It is characterized by the recurrent appearance of itch and subsequent strip-shaped wheals induced by applying shear forces on the skin, such as stroking or rubbing. The impossibility to avoid symptom's occurrence in most cases leads to a marked quality-of-life (QoL) impairment. As of yet, a validated and disease-specific instrument to adequately assess QoL in patients with SD is not available.
Objective: To validate the first disease-specific patient-reported outcome measure to assess health-related QoL impairment in patients with SD, the Symptomatic Dermographism Quality-of-Life Questionnaire (SD-QoL).
Methods: A 13-item QoL questionnaire had been previously generated and published. Now, the SD-QoL was analyzed regarding its domain structure and tested for its reliability and validity by evaluating its internal consistency, test-retest reliability, and convergent and known-groups validity.
Results: In total, 106 patients with SD participated in the SD-QoL validation study. The results suggest a 3-domain structure ("symptoms," "functioning," and "emotions"/"appearance") with an excellent internal consistency of the domains as well as the overall instrument. Furthermore, the analyses indicated high levels of convergent validity and known-groups validity as well as an excellent test-retest reliability.
Conclusions: The SD-QoL is the first validated disease-specific QoL instrument for SD that allows assessing QoL of patients with SD in clinical trials as well as in routine patient care.
Objective: To validate the first disease-specific patient-reported outcome measure to assess health-related QoL impairment in patients with SD, the Symptomatic Dermographism Quality-of-Life Questionnaire (SD-QoL).
Methods: A 13-item QoL questionnaire had been previously generated and published. Now, the SD-QoL was analyzed regarding its domain structure and tested for its reliability and validity by evaluating its internal consistency, test-retest reliability, and convergent and known-groups validity.
Results: In total, 106 patients with SD participated in the SD-QoL validation study. The results suggest a 3-domain structure ("symptoms," "functioning," and "emotions"/"appearance") with an excellent internal consistency of the domains as well as the overall instrument. Furthermore, the analyses indicated high levels of convergent validity and known-groups validity as well as an excellent test-retest reliability.
Conclusions: The SD-QoL is the first validated disease-specific QoL instrument for SD that allows assessing QoL of patients with SD in clinical trials as well as in routine patient care.
Author(s)
Open Access
File(s)
Rights
CC BY 4.0: Creative Commons Attribution
Additional link
Language
English